Indication
Local anesthesia adjunct
The phrase "local anesthesia adjunct" refers to a procedural and pharmacologic supportive indication rather than a distinct pathologic disease or medical condition. Read more about Local anesthesia adjunct
139 drugs 54 manufacturers
Drugs that treat it
Common Local anesthesia adjunct therapies.
MIDAZOLAM HCL
MIDAZOLAM HCL
MIDAZOLAM HCL
MIDAZOLAM HCL
MIDAZOLAM HCL (midazolam HCl/PF)
MIDAZOLAM HCL (midazolam HCl/PF)
MIDAZOLAM HCL (midazolam HCl/PF)
MIDAZOLAM (PF) (midazolam HCl/PF)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonThe phrase "local anesthesia adjunct" refers to a procedural and pharmacologic supportive indication rather than a distinct pathologic disease or medical condition.
It denotes the clinical practice of co-administering secondary agents alongside local anesthetics to enhance regional or infiltration blockade in surgical, dental, obstetric, or interventional pain settings.
This approach targets the peripheral and central nervous systems, as well as local microvasculature, to prolong the duration of analgesia, accelerate block onset, improve block quality, and limit systemic toxicity by reducing the total required dose of the primary local anesthetic.
Clinically, these agents address the limitations of standard neural blockade by counteracting rapid drug clearance, reducing postoperative pain rebound, and mitigating common complications associated with higher doses of local anesthetics.
- nih.gov
The phrase "local anesthesia adjunct" refers to a procedural and pharmacologic supportive indication rather than a distinct pathologic disease or medical condition Clinically, these agents address the limitations of standard neural blockade by counteracting rapid drug clearance, reducing postoperative pain rebound, and mitigating common complications associated with higher doses of local anesthetics
- nih.gov
The phrase "local anesthesia adjunct" refers to a procedural and pharmacologic supportive indication rather than a distinct pathologic disease or medical condition It denotes the clinical practice of co-administering secondary agents alongside local anesthetics to enhance regional or infiltration blockade in surgical, dental, obstetric, or interventional pain settings This approach targets the peripheral and central nervous systems, as well as local microvasculature, to prolong the duration of a...
- nih.gov
It denotes the clinical practice of co-administering secondary agents alongside local anesthetics to enhance regional or infiltration blockade in surgical, dental, obstetric, or interventional pain settings
- nih.gov
It denotes the clinical practice of co-administering secondary agents alongside local anesthetics to enhance regional or infiltration blockade in surgical, dental, obstetric, or interventional pain settings
- nih.gov
This approach targets the peripheral and central nervous systems, as well as local microvasculature, to prolong the duration of analgesia, accelerate block onset, improve block quality, and limit systemic toxicity by reducing the total required dose of the primary local anesthetic Clinically, these agents address the limitations of standard neural blockade by counteracting rapid drug clearance, reducing postoperative pain rebound, and mitigating common complications associated with higher doses ...
Personalize your experience
Follow Local anesthesia adjunct and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.